3SBio (TRSBF) Days Payable : 74.77 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is 3SBio Days Payable?

3SBio's average Accounts Payable for the six months ended in Dec. 2023 was $34 Mil. 3SBio's Cost of Goods Sold for the six months ended in Dec. 2023 was $83 Mil. Hence, 3SBio's Days Payable for the six months ended in Dec. 2023 was 74.77.

The historical rank and industry rank for 3SBio's Days Payable or its related term are showing as below:

TRSBF' s Days Payable Range Over the Past 10 Years
Min: 43.42 Med: 71.52 Max: 106.97
Current: 76.74

During the past 10 years, 3SBio's highest Days Payable was 106.97. The lowest was 43.42. And the median was 71.52.

TRSBF's Days Payable is ranked worse than
63.73% of 714 companies
in the Biotechnology industry
Industry Median: 148.12 vs TRSBF: 76.74

3SBio's Days Payable increased from Dec. 2022 (71.96) to Dec. 2023 (74.77). It may suggest that 3SBio delayed paying its suppliers.

3SBio Days Payable Historical Data

The historical data trend for 3SBio's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio Days Payable Chart

3SBio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

52.23

58.88

70.67

76.68

72.67

3SBio Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															69.02	87.25	71.96	83.09	74.77

Competitive Comparison of 3SBio's Days Payable

For the Biotechnology subindustry, 3SBio's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3SBio's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio's Days Payable distribution charts can be found below:

* The bar in red indicates where 3SBio's Days Payable falls into.

3SBio Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

3SBio's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (35.791	+	29.7)	/	2 )	/	164.463	*	365
=	32.7455					/	164.463	*	365
=	72.67

3SBio's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (38.243	+	29.7)	/	2 )	/	82.914	*	365 / 2
=	33.9715					/	82.914	*	365 / 2
=	74.77

3SBio Days Payable Related Terms

Thank you for viewing the detailed overview of 3SBio's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

3SBio (TRSBF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (OTCPK:TRSBF) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

01530:Hong Kong 83B:Germany

Address

No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027

Website

https://www.3sbio.com

3SBio Inc, or 3SBio, is one of the largest and most established biotech drugmakers in China. In 2021, it reported revenue of CNY 6.3 billion. Approximately 90% of its revenue is derived from four core drugs: TPIAO (rhTPO), Yisaipu (biosimilar of etanercept, a TNF-alpha inhibitor), rhEPO, and Mandi (minoxidil). With the exception of minoxidil, an over-the-counter drug, the others are all older generation biologics. Most of the pipeline candidates are "me-too" drugs and in general are still at an early stage.

3SBio (TRSBF) Headlines

No Headlines